One of the best ways to increase compliance when treating diabetes is to ensure patients fully understand the importance of treatment, according to Yehuda Handelsman, MD, FACP, FACE, FNLA, medical director and principal investigator at the Metabolic Institute of America. However, this can be difficult for physicians with a limited amount of time for patient visits.
One of the best ways to increase compliance when treating diabetes is to ensure patients fully understand the importance of treatment, according to Yehuda Handelsman, MD, FACP, FACE, FNLA, medical director and principal investigator at the Metabolic Institute of America. However, this can be difficult for physicians with a limited amount of time for patient visits.
Transcript (slightly modified)
Physicians cite compliance as a common barrier to diabetes treatment. What can they do to improve compliance?
It’s one of the toughest questions, because, you know, we see the patient [for a short amount of time]—I am a consultant, so I may see them longer, let’s say half an hour, 40 minutes, 35 minutes. Many of the primary care physicians dealing directly with patients may see them only for 12 minutes, 15 minutes, occasionally 10 minutes. So we don’t have that much time to see what the patient is doing in the 3 to 6 months that we don’t see them in between visits.
I think, again, it’s making sure that the patient understands how simple it is to use and how important it is for them to get the glucose under control. Getting the patients buying into the treatment, not to just drop it on them. Discuss why we do it, make sure that they understand and they are willing to adopt that treatment way. So it’s not just for them to think that I think it’s good for them, but for them to actually believe, yes, it is good for us and therefore we ought to do that.
Exclusive Telemedicine Use Linked to Less Favorable Glycemic Outcomes for T2D Endocrinology Care
December 6th 2023Adults with type 2 diabetes (T2D) undergoing endocrinology care are more likely to experience less favorable hemoglobin A1c improvements if they only use telemedicine compared with patients using in-person care or a mix of both.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More